Overview of long noncoding RNAs as competing endogenous RNAs in lung cancer
CeRNA | Target miRNA | mRNA | Expression | Key factors and pathways | Biological functions | Tumor types | CeRNA role | References |
---|---|---|---|---|---|---|---|---|
LINC01123 | MiR-199a-5p | C-myc | Upregulated | – | Proliferation | NSCLC | Oncogene | 25 |
Linc00173 | MiR-218 | Etk | Upregulated | β-catenin signaling | Proliferation, migration-invasion | SCLC | Oncogene | 26 |
HOTAIR | MiR-214-3p | PDPK1 | Upregulated | – | Growth | NSCLC | Oncogene | 27 |
TTN-AS1 | MiR-142-5p | CDK5 | Upregulated | EMT( TWIST1, Twist, Snail and ZEB1) | Proliferation, migration and invasion | LUAD | Oncogene | 28 |
PVT1 | MiR-199a-5p | HIF1α | Upregulated | – | Migration and proliferation | NSCLC | Oncogene | 29 |
LINC00336 | MIR6852 | CBS | Upregulated | P53 pathway | Proliferation | NSCLC | Oncogene | 30 |
LCAT1 | MiR-4715-5p | RAC1 | Upregulated | – | Proliferation, migration and invasion | Lung cancer | Oncogene | 31 |
TINCR | MiR-544a | FBXW7 | Downregulated | – | Proliferation and invasion | Lung cancer | Suppressor | 32 |
NNT-AS1 | MiR-129-5p | NNT-AS1 | Upregulated | – | Proliferation, migration and invasion | NSCLC | Oncogene | 33 |
UCA1 | MiR-193a | HMGB1 | Upregulated | – | Proliferation and migration | Lung cancer | Oncogene | 34 |
H19 | MicroRNA-107 | NF1 | Upregulated | – | Proliferation and migration | NSCLC | Oncogene | 35 |
PVT1-5 | MiR-126 | SLC7A5 | Upregulated | – | Proliferation | Lung cancer | Oncogene | 36 |
XLOC_008466 | MiR-874 | MMP2/XIAP | Upregulated | – | Proliferation, apoptosis and invasion | NSCLC | Oncogene | 37 |
HOTTIP | MiR-574-5p | EZH1 | Upregulated | – | Proliferation | SCLC | Oncogene | 38 |
LINC01234 | MiR-140 | OTUB1 | Upregulated | SP1 | Proliferation, metastasis and apoptosis | NSCLC | Oncogene | 39 |
LINC00858 | MiR-422a | KLK4 | Upregulated | – | Proliferation | NSCLC | Oncogene | 40 |
SNHG7 | MiR-193b | FAIM2 | Upregulated | E-cadherin, N-cadherin | Proliferation, apoptosis and metastasis | NSCLC | Oncogene | 41 |
ZEB1-AS1 | MiR-409-3p | ZEB1 | Upregulated | Caspase 3, Bax and Bcl-2 | Proliferation, apoptosis | NSCLC | Oncogene | 42 |
MALAT1 | MiR-124 | STAT3 | Upregulated | STAT3 | Proliferation, colony formation and apoptosis | NSCLC | Oncogene | 43 |
H19 | MiR-17 | STAT3 | Upregulated | STAT3 | Growth, migration and invasion | NSCLC | Oncogene | 44 |
NR2F2-AS1 | MiR-320b | BMI1 | Upregulated | – | Apoptosis, Proliferation and invasion | NSCLC | Oncogene | 45 |
OGFRP1 | MiR-124-3p- | LYPD3 | Upregulated | EMT, caspase-9 and caspase-3 | Proliferation, apoptosis, migration and invasion | NSCLC | Oncogene | 46 |
PTCH1 | MiR-101-3p | SLC39A6 | Upregulated | Hh pathway, Vimentin, N-cadherin (CDH2) | Migration, invasion and adhesion | NSCLC | Oncogene | 47 |
NEAT1 | MiR-377-3p | E2F3 | Upregulated | P57, p21 and Bcl2 | Growth, apoptosis, migration and invasion | NSCLC | Oncogene | 48 |
HOXA11-AS | MiR-454-3p | Stat3 | Upregulated | Cleaved-caspase-3/9, EMT (Snail, Twist) | Proliferation, apoptosis, metastasis | LUAD | Oncogene | 49 |
PRNCR1 | MiR-448 | HEY2 | Upregulated | EMT | Proliferation, invasion and migration | NSCLC | Oncogene | 50 |
LncRNA 1308 | MiR-124 | ADAM 15 | Upregulated | – | Proliferation, apoptosis, invasion and migration | NSCLC | Oncogene | 51 |
FLVCR1-AS1 | MiR-573 | E2F3 | Upregulated | – | Proliferation, migration and invasion | NSCLC | Oncogene | 52 |
LINC00641 | MiR-424-5p | PLSCR4 | Downregulated | – | Proliferation, apoptosis and migration | NSCLC | Suppressor | 53 |
TP73-AS1 | MiR-449a | EZH2 | Upregulated | – | Proliferation, growth | NSCLC | Oncogene | 54 |
XIST | MiR-137 | PXN | Upregulated | – | Invasion | NSCLC | Oncogene | 55 |
MYEOV | MiR-30c-2-3p | TGFBR2, USP15 | Upregulated | TGF-β/SMAD pathway | Invasion and metastasis | NSCLC | Oncogene | 56 |
NEAT1 | Mir-193a-3p | USF1 | Upregulated | Caspase-3/7 | Proliferation, apoptosis, invasion and migration | LUAD | Oncogene | 57 |
LINC00702 | MiR-510 | PTEN | Downregulated | PTEN pathway, AKT pathway | Proliferation, apoptosis, invasion | NSCLC | Suppressor | 58 |
MALAT1 | MiR-200b | ZEB1, E2F3 | Upregulated | EMT, TFAP2C, ZEB1, E2F3 | Proliferation, apoptosis and metastasis | LUAD | Oncogene | 59 |
HOXD-AS1 | MiR-147a | PRB | Upregulated | – | Growth, proliferation, apoptosis | NSCLC | Oncogene | 60 |
DANCR | MiR-138 | Sox4 | Upregulated | EMT | Proliferation, apoptosis, migration, invasion | NSCLC | Oncogene | 61 |
DGCR5 | MiR-211-5p | EPHB6 | Downregulated | – | Growth, migration and invasion | NSCLC | Suppressor | 62 |
SNHG20 | MiR-154 | ZEB2, RUNX2 | Upregulated | – | Proliferation, migration and invasion, apoptosis, growth | NSCLC | Oncogene | 63 |
XIST | MiR-367/141 | ZEB2 | Upregulated | TGF-β induced EMT | Migration and invasion | NSCLC | Oncogene | 64 |
LIN28B | Let-7 | HMGA2 | Upregulated | TGFBR3 | Migration and invasion | NSCLC | Oncogene | 65 |
DLX6-AS1 | MiR-144 | PRR11 | Upregulated | – | Proliferation, apoptosis, invasion and migration | NSCLC | Oncogene | 66 |
SBF2-AS1 | MiR-338-3p/ 362-3p | E2F1 | Upregulated | Cyclin D1, p21 | Proliferation | LUAD | Oncogene | 67 |
SNHG6 | MiR-26a-5p | E2F7 | Upregulated | EMT | Proliferation, migration and invasion | LUAD | Oncogene | 68 |
Linc00668 | MiR-147a | Slug | Upregulated | EMT | Proliferation, migration and invasion | NSCLC | Oncogene | 69 |
DANCR | MiR-496 | mTOR | Upregulated | mTOR pathway | Proliferation, migration and invasion, apoptosis, growth | LUAD | Oncogene | 70 |
HMMR-AS1 | MiR-138 | SIRT6 | Upregulated | – | Apoptosis, Proliferation | LUAD | Oncogene | 71 |
GMDS-AS1 | MiR-96-5p | CYLD | Upregulated | Bax, Bcl-2 and PCNA | Proliferation, apoptosis | LUAD | Suppressor | 72 |
LINC00667 | MiR-143-3p | RRM2 | Downregulated | CDK2 and p-AKT | Growth, Proliferation | NSCLC | Oncogene | 73 |
Linc00673 | MiR-150-5p | ZEB1 | Upregulated | TGFB1/Smad, EMT (Snail, ZEB1) | Apoptosis, Proliferation, migration and invasion | NSCLC | Oncogene | 74 |
SNHG1 | MiR-145-5p | MTDH | Upregulated | EMT, TGF-β | Proliferation, migration and invasion | NSCLC | Oncogene | 75 |
NEAT1 | Let-7a | IGF-2 | Upregulated | P53, p21, EMT, IGF-2 signaling pathway | Apoptosis, Proliferation, invasion and migration, growth | NSCLC | Oncogene | 76 |
NEAT1 | MiR-377-3p | E2F3 | Upregulated | P21 p57 | Growth, Proliferation | NSCLC | Oncogene | 77 |
LINC81507 | MiR-199b-5p | CAV1 | Downregulated | STAT3 pathway | Proliferation, metastasis, migration and invasion | NSCLC | Suppressor | 78 |
NORAD | MiR-136-5p | E2F1 | Upregulated | – | Proliferation | NSCLC | Oncogene | 79 |
MINCR | MiR-126 | SLC7A5 | Upregulated | – | Proliferation , migration, apoptosis, growth | NSCLC | Oncogene | 80 |
JPX | MiR-145-5p | Cyclin D2 | Upregulated | CCND2 | Proliferation, colony formation and migration | NSCLC | Oncogene | 81 |
MEG3 | MicroRNA-7-5p | BRCA1 | Downregulated | Bcl-2 and Bax | Apoptosis | NSCLC | Suppressor | 82 |
NEAT1 | MiR-98-5p | MAPK6 | Upregulated | BCL-2 , MMP-9, MMP-2 | Growth, migration and invasion | NSCLC | Oncogene | 83 |
XIST | Let-7i | BAG-1 | Upregulated | – | Apoptosis, Proliferation | LUAD | Oncogene | 84 |
PVT1 | MiR-216b | Beclin-1 | Upregulated | BCL2, Bax | Apoptosis | NSCLC | Oncogene | 85 |
LINC00707 | MiR-145 | MRP1 | Upregulated | Bcl-2 and Bax | Apoptosis | NSCLC | Oncogene | 86 |
XIST | MiR-374a | LARP1 | Upregulated | P-STAT3, cyclin D1 | Proliferation, migration and invasion | NSCLC | Oncogene | 87 |
LINC00485 | MiR-195 | CHEK1 | Upregulated | Bax, Bcl-2, VEGF, HIF-1α | Proliferation, apoptosis | LUAD | Oncogene | 88 |
Linc00665 | MiR-98 | AKR1B10 | Upregulated | EMT, Bcl-2, Bax, ERK, p-ERK and SP1 | Proliferation, migration, invasion, apoptosis, growth | LUAD | Oncogene | 89 |
HOTTIP | MiR-216a | BCL-2 | Upregulated | BCL-2 | Apoptosis | SCLC | Oncogene | 90 |
XIST | MiR-449a | Bcl-2 | Upregulated | PARP-1, caspase-9 and Bcl-2 | Growth, apoptosis, migration and invasion | NSCLC | Oncogene | 91 |
ZFAS1 | MiR-150-5p | HMGA2 | Upregulated | – | Proliferation, invasion, apoptosis | NSCLC | Oncogene | 92 |